7774

Japan Tissue Engineering Co.,Ltd.

ジャパン・ティッシュエンジニアリング

Industry
Precision Instruments
Market
Growth
Accounting standards
Japanese GAAP
Consolidation basis
Non-consolidated

Key metrics

Revenue(thousand JPY)

Mar 2021
2,257,609
Mar 2022
2,103,443
Mar 2023
2,032,448
Mar 2024
2,514,190
Mar 2025
2,455,474

Operating profit(thousand JPY)

Mar 2021
-466,861
Mar 2022
-498,182
Mar 2023
-728,119
Mar 2024
144,506
Mar 2025
-238,315

Operating profit margin(%)

Mar 2021
-20.68
Mar 2022
-23.68
Mar 2023
-35.82
Mar 2024
5.75
Mar 2025
-9.71

Profit before tax(thousand JPY)

Mar 2021
-462,782
Mar 2022
-494,049
Mar 2023
-725,477
Mar 2024
147,009
Mar 2025
-234,487

Profit(thousand JPY)

Mar 2021
-466,622
Mar 2022
-497,889
Mar 2023
-729,317
Mar 2024
143,169
Mar 2025
-255,304

Total assets(thousand JPY)

Mar 2021
8,119,186
Mar 2022
7,598,156
Mar 2023
6,883,320
Mar 2024
6,988,774
Mar 2025
6,512,990

Cash and cash equivalents(thousand JPY)

Mar 2021
1,875,871
Mar 2022
1,533,319
Mar 2023
2,034,570
Mar 2024
2,066,344
Mar 2025
1,685,449

Cash flows from operating activities(thousand JPY)

Mar 2021
-399,586
Mar 2022
-225,248
Mar 2023
-622,600
Mar 2024
274,138
Mar 2025
-148,365

Cash flows from investing activities(thousand JPY)

Mar 2021
125,886
Mar 2022
-116,479
Mar 2023
1,124,654
Mar 2024
-242,230
Mar 2025
-232,526

Cash flows from financing activities(thousand JPY)

Mar 2021
-1,305
Mar 2022
-823
Mar 2023
-803
Mar 2024
-134
Mar 2025
-3

Return on equity(%)

Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
2.38
Mar 2025
-

Equity ratio(%)

Mar 2021
88.2
Mar 2022
87.7
Mar 2023
86.3
Mar 2024
87
Mar 2025
89.4

Earnings per share(JPY per share)

Mar 2021
-11.49
Mar 2022
-12.26
Mar 2023
-17.96
Mar 2024
3.53
Mar 2025
-6.29

Net assets per share(JPY per share)

Mar 2021
176.42
Mar 2022
164.16
Mar 2023
146.2
Mar 2024
149.73
Mar 2025
143.44

Dividend per share(-)

Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-

Payout ratio(-)

Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.